Share Twitter LinkedIn Facebook Email Ghassan Abou-Alfa, MD, MBA, explains how immunotherapies should be combined with TKIs at Annual Meeting 2018.
Sumanta (Monty) Kumar Pal, MD – Highlights and Insights from MOASC 2024 Summit: Pioneering Oncology Research and Celebrating Young Investigators General 3 Mins Read